Zhongzhi Weiye Information | Q3 Financial Results of the World’s Top 50 Chemical Companies Released!

Lanxess: Q3 sales amounted to €1.601 billion, down 26.7% year-on-year; EBITDA stood at €119 million, down 50.4%; net income declined from €80 million in the prior year to -€131 million. Wacker Chemie AG: Group sales for Q3 totaled €1.52 billion, down 29% year-on-year; EBITDA was €152 million, down 67%; net profit for Q3 was €34 million. Clariant: Organic sales for Q3 reached CHF 1.031 billion, down 8% year-on-year; EBITDA margin fell to 15.4%, compared to 16.8% in the same period last year. Cumulative sales for the first three quarters of 2023 totaled CHF 3.315 billion, down 7% year-on-year. North America Dow: Net sales for Q3 were $10.7 billion, down 24% year-on-year; GAAP net income was $327 million, versus $760 million in the prior-year quarter. LyondellBasell: Sales revenue for Q3 was $10.625 billion, down 13.3% year-on-year from $12.25 billion; EBITDA was $1.356 billion, up 21.8% from $1.108 billion in the prior-year quarter. Sherwin-Williams: Net sales for Q3 were $6.117 billion, up 1.1%; net income was $298 million, up 10.7%; EBITDA was $1.27 billion, up 12.6%. Nutrien: Sales for Q3 were $5.631 billion, down 31% year-on-year from $8.188 billion; net income was $82 million, down 95% from $1.853 billion in the prior-year quarter. PPG: Net sales for Q3 were $4.644 billion, up 4% year-on-year; net income was $430 million, up 29%. Ecolab: Net sales for Q3 were $3.958 billion, up 8% from $3.669 billion in the prior year; net income was $404 million, up 16% from $347 million in the prior-year quarter. Mosaic: Revenue for Q3 was $3.5 billion, down ~34% year-on-year; net loss was $4 million, versus net income of $842 million in the prior-year quarter; EBITDA was $594 million, down 65%. Westlake Chemical Corporation: Net sales for Q3 were $3.115 billion, down 21.3% year-on-year; net income was $285 million, down 46.5%; EBITDA was $682 million, down 15%. DuPont: Net sales for Q3 were $3.1 billion, down 8% year-on-year; operating EBITDA was $775 million. Air Products: Sales for Q3 were $3.034 billion, down 4.8% year-on-year; GAAP net income was $2.01 billion, up 170%; adjusted EBITDA was $3.9 billion, up 8%. International Flavors & Fragrances (IFF): Net sales for Q3 were $2.82 billion, down 8% year-on-year; EBITDA was $506 million, down 10%.

ICIS Global Top 100 Chemical Companies: Who Is Truly Strong, and Who Is Just Bloated? What Will Define Future Competition in the Chemical Industry?

After all, there are few remaining growth opportunities in the chemical industry, and the traditional model of competing solely on scale has already lost its effectiveness. Friends of Wanhua Chemical—what do you think are Wanhua’s key breakthrough points going forward? III. The Largest Company Is Not Necessarily the Most Profitable Another notable trend revealed by this year’s ranking data is the growing divergence between scale and profitability. Among the global top 10, eight companies disclosed operating profit and EBIT figures. Their combined sales totaled approximately $366.2 billion, while their aggregate EBIT amounted to only about $2.66 billion—representing a weighted EBIT margin of just ~0.7%. In contrast, among the 83 companies ranked 11th–100th that disclosed EBIT, the weighted EBIT margin stood at ~4.2%. Wanhua and Rongsheng did not disclose EBIT figures; therefore, the 0.7% figure does not represent the full top-10 average, and differences in business scope and financial reporting standards across companies further limit comparability. Although the data may not be perfectly precise, the disparity is real and striking: the world’s largest chemical enterprises are not necessarily those with the strongest profit conversion capability. BASF serves as the most typical example: with 2025 sales of $70.004 billion—the highest globally—it reported operating profit of $1.917 billion. Shin-Etsu Chemical, with sales of $16.413 billion—less than one-quarter of BASF’s—reported operating profit of $4.05 billion, more than double BASF’s. BASF is bigger; Shin-Etsu is more profitable. These two companies operate in fundamentally different businesses, with differing asset intensities, cyclical exposures, customer relationships, and pricing power. Sales volume merely indicates which company is larger—not which is stronger. IV. The Global Chemical Industry Is Not Deteriorating Uniformly—It Is Accelerating Its Polarization Among the Top 100, 91 companies disclosed EBIT: 53 posted operating margins below 5%; 26 reported operating losses; and 20 maintained double-digit EBIT margins. The global chemical industry is undergoing severe polarization amid general sluggishness. Covestro reported an operating loss of $407 million; Westlake Chemical, $1.426 billion; Celanese, $786 million; Versalis, $1.672 billion; FMC, $1.647 billion. Meanwhile, Shin-Etsu, NewMarket, and Givaudan continue to demonstrate strong profit-conversion capabilities. If all companies deteriorated simultaneously, it would likely reflect a broad cyclical downturn. But within the same cycle, some suffer massive losses while others sustain operating margins above 20%. This underscores the growing importance of product mix, cost positioning, customer switching costs, technological barriers, and capital intensity. The cycle hasn’t disappeared—but it has magnified previously hidden differences among business models. V. What Matters Is Not Simply Pursuing ‘High-End’ Products, But the Quality of the Product Portfolio Commodity chemicals face persistent margin pressure, whereas specialty chemicals show relatively robust profitability—leading many to define strategic direction simply as ‘moving upmarket.’ Yet, summarizing the situation as ‘commodity = bad, specialty = good’ is an oversimplification—and insufficient as a sound commercial judgment. A commodity chemical enterprise possessing low-cost feedstocks, highly efficient assets, and a globally leading cost curve can still generate excellent returns on capital. Conversely, a so-called specialty chemical company—whose products lack meaningful barriers to entry, whose customers face negligible switching costs, and into which competitors can easily enter—may struggle to earn any meaningful profit.

Westlake Chemical Partners outlines growth levers as it reports $0.4714 quarterly distribution and no planned 2026 turnarounds

May 6, 2026

Westlake Chemical Partners reported a $0.4714 quarterly distribution for Q1 2024, marking 39 consecutive quarters of stable payouts. The company confirmed no planned turnarounds for 2026 at its Calvert City facilities to support future growth.

MSN

2026-05-05

Westlake Chemical Partners LP Reports Q1 Revenue $305.7M, Below FactSet Estimate

2026-05-06

Westlake Chemical Partners LP (NYSE:WLKP) Q1 2026 Earnings Call Transcript

2026-05-06

Westlake Chemical Partners outlines growth levers as it reports $0.4714 quarterly distribution and no planned 2026 turnarounds

2026-05-07

Westlake Chemical Partners (WLKP) EPS Growth And 8.04% Yield Test Income Bull Narrative

2026-05-22

Westlake Chemical Partners Balances Stability and Limited Upside